Status:
RECRUITING
BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
Lead Sponsor:
University of Valencia
Conditions:
Idiopathic Intracranial Hypertension (IIH)
Eligibility:
All Genders
18+ years
Brief Summary
1. To establish the correlation between the evolution of the body mass index in benign intracranial hypertension and the response to treatments. 2. To establish the BMI at which this disease occurs. 3...
Detailed Description
There is unanimity that one of the causes of benign intracranial hypertension is obesity. However, there is no agreement on the upper limit of BMI above which this disease occurs or the lower limit ab...
Eligibility Criteria
Inclusion
- Adults aged 18 years and older at the time of enrollment. There is no upper age limit to ensure inclusivity across age ranges.
- A confirmed diagnosis of Idiopathic Intracranial Hypertension, established according to the Dandy criteria.
- The diagnostic process must exclude other potential causes of increased intracranial pressure as detailed in the 'Diagnosis' section, ensuring an accurate identification of idiopathic cases.
Exclusion
- A diagnosis other than IIH, specifically: tension-type headache, Chiari I malformation, or any other headache disorder unrelated to IIH.
- The presence of secondary causes of increased intracranial pressure (e.g., structural brain abnormalities, venous sinus thrombosis, or medication-induced factors).
Key Trial Info
Start Date :
June 27 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06913712
Start Date
June 27 2024
End Date
April 1 2027
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Consorcio Hospital General Universitario de Valencia
Valencia, Valencia, Spain, 46015